Medical Advocates for Social Justice
Tenofovir Disoproxil Fumarate (Viread)
 
Drug Alerts/Warning Letters


TNF/ATZ
TNF/DDI/+either EFV or NVP
TNF/3TC/ABC
Promotional Activities



 

  
Tenofovir Main Page Main New/Newsworthy Home Page      

Last Update:  May 25, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the  Adobe Acrobat Reader 6 .
Tenofovir/Atazanavir
         

Internet Documents
 
  Drug Alert from BMS:  Important New Pharmacokinetic Data for REYATAZ (atazanavir
sulfate) in combination with Viread (tenofovir disoproxil fumarate)
Sally Hodder, MD
 August 08, 2003
 PDF Letter

Tenofovir/Didanosine and either Efavirenz or
Nevirapine

Internet Documents
 
  BMS Warning Letter: Important New Clinical Data Potential Early Virologic Failure
Associated with the Combination Antiretroviral Regimen of Tenofovir Disoproxil Fumarate,
Didanosine, and Either Efavirenz or Nevirapine in HIV Treatment-Naïve Patients with High
Baseline Viral Loads
Sally L. Hodder, MD,
 November 2004
 PDF Letter

Tenofovir/Lamivudine/Abacavir
         

Internet Documents
 
  FULL-TEXT PDF DOCUMENT
 EMEA Public Statement on Early Virologic Non- Response in Patient with HIV-Infection
Treated with Tenofovir in Combination with Lamivudine and Abacavir
 July 30, 2003
 EMEA Web Site
 

Promotional Activities
         

Internet Documents
 
  FDA Sends Warning Letter to Gilead on Viread Promotional Activities
 July 29, 2003
 PDF Letter

Tenofovir Main Page Main New/Newsworthy Home Page      

Tenofovir Drug Alerts/Warning Letters